Emergence of new pandemic GII.4 Sydney norovirus strain correlates with escape from herd immunity |
|
Functional analysis of connexin mutations involved in genetic deafness / Martina Beltramello ; coordinatore: Tullio Pozzan ; supervisore: Fabio Mammano |
|
Human antibodies against dengue enhance dengue viral infectivity without suppressing type I interferon secretion in primary human monocytes |
|
A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential |
|
The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity |
|
Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae |
|
Immunogenetic mechanisms driving norovirus GII.4 antigenic variation |
|
Impaired permeability to Ins(1,4,5)P3 in a mutant connexin underlies recessive hereditary deafness |
|
In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection |
|
Particle conformation regulates antibody access to a conserved GII.4 norovirus blockade epitope |
|
Pathogenetic role of the deafness-related M34T mutation of Cx26. |
|
Permeability and gating properties of human connexins 26 and 30 expressed in HeLa cells |
|
Rational engineering of a human anti-dengue antibody through experimentally validated computational docking |
|
Serum Immunoglobulin A Cross-Strain Blockade of Human Noroviruses |
|
Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected]. |
|
Within-host evolution results in antigenically distinct GII.4 noroviruses |
|